<DOC>
	<DOCNO>NCT00173641</DOCNO>
	<brief_summary>Evaluate regulatory T cell function patient type 1 diabetes mellitus , find pathogenesis autoimmune disease .</brief_summary>
	<brief_title>The Role Regulatory T Cell Patients With Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>Type 1 diabetes mellitus ( T1D ) autoimmune disease characterize T cell mediate destruction pancreatic βcell . Dysregulated B T cell report animal model . The loss maintenance immune homeostasis think major mechanism result persistence autoreactive T cell periphery . Therapies modulate immune dysfunction may helpful patient T1D . Immune homeostasis mean balance response control infection tumor growth reciprocal response prevent inflammation autoimmune disease . CD4+ CD25+ regulatory T cell ( Tregs ) critical maintain function . Their action cell-to-cell contact bystander effect . The specific marker Tregs include CD25 molecule ( IL-2 receptorαchain ) , Foxp3 ( forkhead-winged helix transcription factor ) . The Foxp3 transcription factor control gene encode Tregs associate molecule , CD25 , CTLA-4 GITR . The previous study modulation Tregs T1D show positive result animal model . But relative size CD4+CD25+ population human still controversial . Our hypothesis imbalance Tregs autoreactive T cell pathogenesis T1D . Therefore , use flow cytometry determine number CD4+CD25+ Tregs population quantitative real-time PCR assay expression Foxp3 , CLTA-4 , GITR patient different stage normal control . Besides , autoantibodies GAD65 associate T1D 60-80 % patient . It marker autoimmune diabetes . We anticipate realization Tregs function patient T1D help guide immunotherapy patient T1D autoimmune disease .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>pediatric type 1 DM</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>